Short-Chain Fatty Acids and Their Metabolic Interactions in Heart Failure

Overview

Journal Biomedicines

Specialty Biomedical Engineering

Date 2025 Feb 26

PMID 40002756

Authors

Laura Chulenbayeva

Argul Issilbayeva

Aliya Sailybayeva

Makhabbat Bekbossynova

Samat Kozhakhmetov

Almagul Kushugulova

Affiliations

Soon will be listed here.

Abstract

Short-chain fatty acids (SCFAs), produced through fermentation of dietary fibers by gut bacteria, play a central role in modulating cardiovascular function and heart failure (HF) development. The progression of HF is influenced by intestinal barrier dysfunction and microbial translocation, where SCFAs serve as key mediators in the gut-heart axis. This review examines the complex metabolic interactions between SCFAs and other gut microbiota metabolites in HF, including their relationships with trimethylamine N-oxide (TMAO), aromatic amino acids (AAAs), B vitamins, and bile acids (BAs). We analyze the associations between SCFA production and clinical parameters of HF, such as left ventricular ejection fraction (LVEF), N-terminal pro-B-type natriuretic peptide (NT-proBNP), and glomerular filtration rate (GFR). Gaining insights into metabolic networks offers new potential therapeutic targets and prognostic markers for managing heart failure, although their clinical significance needs further exploration.

References

Mayerhofer C, Ueland T, Broch K, Vincent R, Cross G, Dahl C . Increased Secondary/Primary Bile Acid Ratio in Chronic Heart Failure. J Card Fail. 2017; 23(9):666-671. DOI: 10.1016/j.cardfail.2017.06.007. View

Zhou H, Yu B, Sun J, Liu Z, Chen H, Ge L . Short-chain fatty acids can improve lipid and glucose metabolism independently of the pig gut microbiota. J Anim Sci Biotechnol. 2021; 12(1):61. PMC: 8101156. DOI: 10.1186/s40104-021-00581-3. View

Bozkurt B, Coats A, Tsutsui H, Abdelhamid C, Adamopoulos S, Albert N . Universal definition and classification of heart failure: a report of the Heart Failure Society of America, Heart Failure Association of the European Society of Cardiology, Japanese Heart Failure Society and Writing Committee of the Universal.... Eur J Heart Fail. 2021; 23(3):352-380. DOI: 10.1002/ejhf.2115. View

Mullens W, Auricchio A, Martens P, Witte K, Cowie M, Delgado V . Optimized implementation of cardiac resynchronization therapy: a call for action for referral and optimization of care. Europace. 2021; 23(8):1324-1342. DOI: 10.1093/europace/euaa411. View

Zhang S, Zhou J, Wu W, Zhu Y, Liu X . The Role of Bile Acids in Cardiovascular Diseases: from Mechanisms to Clinical Implications. Aging Dis. 2023; 14(2):261-282. PMC: 10017164. DOI: 10.14336/AD.2022.0817. View

Zheng H, Xu P, Jiang Q, Xu Q, Zheng Y, Yan J . Depletion of acetate-producing bacteria from the gut microbiota facilitates cognitive impairment through the gut-brain neural mechanism in diabetic mice. Microbiome. 2021; 9(1):145. PMC: 8235853. DOI: 10.1186/s40168-021-01088-9. View

Imazu M, Fukuda H, Kanzaki H, Amaki M, Hasegawa T, Takahama H . Plasma indoxyl sulfate levels predict cardiovascular events in patients with mild chronic heart failure. Sci Rep. 2020; 10(1):16528. PMC: 7536212. DOI: 10.1038/s41598-020-73633-9. View

Nagatomo Y, Tang W . Intersections Between Microbiome and Heart Failure: Revisiting the Gut Hypothesis. J Card Fail. 2015; 21(12):973-80. PMC: 4666782. DOI: 10.1016/j.cardfail.2015.09.017. View

Mamic P, Chaikijurajai T, Tang W . Gut microbiome - A potential mediator of pathogenesis in heart failure and its comorbidities: State-of-the-art review. J Mol Cell Cardiol. 2020; 152:105-117. PMC: 7981261. DOI: 10.1016/j.yjmcc.2020.12.001. View

10.

Steenbeke M, Valkenburg S, Gryp T, Van Biesen W, Delanghe J, Speeckaert M . Gut Microbiota and Their Derived Metabolites, a Search for Potential Targets to Limit Accumulation of Protein-Bound Uremic Toxins in Chronic Kidney Disease. Toxins (Basel). 2021; 13(11). PMC: 8625482. DOI: 10.3390/toxins13110809. View

11.

Swer N, Venkidesh B, Murali T, Mumbrekar K . Gut microbiota-derived metabolites and their importance in neurological disorders. Mol Biol Rep. 2022; 50(2):1663-1675. PMC: 9889412. DOI: 10.1007/s11033-022-08038-0. View

12.

Cai K, Ma Y, Cai F, Huang X, Xiao L, Zhong C . Changes of gut microbiota in diabetic nephropathy and its effect on the progression of kidney injury. Endocrine. 2022; 76(2):294-303. DOI: 10.1007/s12020-022-03002-1. View

13.

Modin D, Sengelov M, Jorgensen P, Olsen F, Bruun N, Fritz-Hansen T . Prognostic Value of Left Atrial Functional Measures in Heart Failure With Reduced Ejection Fraction. J Card Fail. 2018; 25(2):87-96. DOI: 10.1016/j.cardfail.2018.11.016. View

14.

Overby H, Ferguson J . Gut Microbiota-Derived Short-Chain Fatty Acids Facilitate Microbiota:Host Cross talk and Modulate Obesity and Hypertension. Curr Hypertens Rep. 2021; 23(2):8. PMC: 7992370. DOI: 10.1007/s11906-020-01125-2. View

15.

Roager H, Licht T . Microbial tryptophan catabolites in health and disease. Nat Commun. 2018; 9(1):3294. PMC: 6098093. DOI: 10.1038/s41467-018-05470-4. View

16.

Wang Y, Koay Y, Pan C, Zhou Z, Tang W, Wilcox J . Indole-3-Propionic Acid Protects Against Heart Failure With Preserved Ejection Fraction. Circ Res. 2024; 134(4):371-389. PMC: 10923103. DOI: 10.1161/CIRCRESAHA.123.322381. View

17.

Ma J, Piao X, Mahfuz S, Long S, Wang J . The interaction among gut microbes, the intestinal barrier and short chain fatty acids. Anim Nutr. 2022; 9:159-174. PMC: 9079705. DOI: 10.1016/j.aninu.2021.09.012. View

18.

Romano K, Nemet I, Saha P, Haghikia A, Li X, Mohan M . Gut Microbiota-Generated Phenylacetylglutamine and Heart Failure. Circ Heart Fail. 2022; 16(1):e009972. PMC: 9851997. DOI: 10.1161/CIRCHEARTFAILURE.122.009972. View

19.

Si X, Shang W, Zhou Z, Strappe P, Wang B, Bird A . Gut Microbiome-Induced Shift of Acetate to Butyrate Positively Manages Dysbiosis in High Fat Diet. Mol Nutr Food Res. 2017; 62(3). DOI: 10.1002/mnfr.201700670. View

20.

Cheng T, Ma M, Liao M, Zheng C, Lu K, Liao C . Indoxyl Sulfate, a Tubular Toxin, Contributes to the Development of Chronic Kidney Disease. Toxins (Basel). 2020; 12(11). PMC: 7693919. DOI: 10.3390/toxins12110684. View